Sebia Overview
- Founded
- 1967

- Status
- Private
- Employees
- 470

- Latest Deal Type
- Buyout/LBO
- Financing Rounds
- 8
Sebia General Information
Description
Provider of clinical protein electrophoresis equipment and reagents technology designed to use for in-vitro diagnostic (IVD) testing. The company's systems analyze proteins in order to screen and monitor various diseases and conditions, primarily oncology, metabolic disorders such as diabetes and also emoglobinopathy and rare pathologies enabling laboratories to make electrophoresis accessible with simply performing systems.
Contact Information
- 27 rue Léonard de Vinci
- Evry Cedex
- 91008 Lisses
- France
Sebia Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Sebia‘s full profile, request access.
Request a free trialSebia Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Benoît Adelus MD | Chairman & Chief Executive Officer |
Sebia Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
0000î0 000000 00 | Self | Chairman & Chief Executive Officer | 000 0000 |
Sebia Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSebia Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Sebia‘s full profile, request access.
Request a free trial